Hypoxia-Ischemia, Brain
29
8
9
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
6.9%
2 terminated out of 29 trials
88.2%
+1.7% vs benchmark
7%
2 trials in Phase 3/4
40%
6 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 15 completed trials
Clinical Trials (29)
buRst-supprESsion TO Stop Refractory Status Epilepticus Post-cardiac Arrest
Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)
ECMO ABI Detection With Hyperfine
Optimizing (Longer, Deeper) Cooling for Neonatal Hypoxic-Ischemic Encephalopathy(HIE)
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
Transauricular Vagus Nerve Stimulation in Children
Neuropsychological Outcome After Cardiac Arrest
Antiseizure Medication in Seizure Networks at Early Acute Brain Injury
Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction
Neuropsychological Rehabilitation Over the Internet
Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset：Longterm Outcome
Preemie Hypothermia for Neonatal Encephalopathy
Functional Imaging of Baby Brains
Early Cessation of Sedation and TTM in Patients With a Favourable EEG After Cardiac Arrest
Delineating Between Pathophysiologic Phenotypes of Hypoxic Ischemic Brain Injury After Cardiac Arrest
Development of a High-speed Multimodal Photoacoustic/Ultrasound System for Functional Imaging of the Neonatal Brain
The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy
Assessing Cerebrovascular Reactivity Based on Cerebral Oximetry: a Pilot Study